Smartcella Holding Ab

SmartCella is a global biopharma company that combines biotech methods and medical science to develop therapies from living systems and pioneers targeted therapies for difficult-to-treat diseases through delivery solutions and advanced therapy development. Founded in 2014, the company is built on globally renowned science and research from Karolinska Institutet in Sweden. SmartCella combines novel delivery platforms, such as the Extroducer® (an endovascular delivery device that enables direct injection to hard-to-reach organs and tumors), with cutting-edge development and manufacturing of cell therapies. The company has two operating segments: Targeted Delivery and Regenerative Medicines. The international team consists of scientists, visionary innovators, and experienced business leaders, all dedicated to shaping the future of targeted therapies and delivering life-changing treatments to patients.